Advertisement

Topics

Companies Related to "Vascular Begins Enrollment Pivotal Study Drug Coated Peripheral" [Most Relevant Company Matches] RSS

17:26 EST 24th November 2017 | BioPortfolio

Here are the most relevant search results for "Vascular Begins Enrollment Pivotal Study Drug Coated Peripheral" found in our extensive corporate database of over 50,000 company records.

Showing "Vascular Begins Enrollment Pivotal Study Drug Coated Peripheral" Companies 1–25 of 4,200+

Extremely Relevant

Vascular Nanotransfer Technologies

Privately held VNT, based in Auburndale, Mass., is developing Drug-Coated Balloons (DCB) that are designed to be a more precise delivery vehicle and be the standard treatment of choice for vascular atherosclerosis as well as non-vascular applications.


Intact Vascular

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Intact Vascular, Inc.

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment paradigm for treating peripheral ...


Intact Vascular, LLC

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Bacchus Vascular, Inc.

Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from D...

Biomedix, Inc

BioMedix is the fastest growing provider of equipment and services in the market for noninvasive detection of peripheral vascular disease (PVD). Unique technology also links PCP's and Vascular Specialists in the early detection of peripheral arterial disease (PAD) through simple web-enabled vascular testing devices, software and services. Innovative Vascular Lab and Surgery suite management softwa...

Relevant

LeMaitre Vascular

LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. Our diversified product portfolio consists of well-known brand name products used in arteries and veins outside of the heart.

Vascular Magnetics, Inc.

Vascular Magnetics is developing novel therapeutic products based on the magnetic targeting of drug-loaded biodegradable particles. The company’s first product in development is a treatment for peripheral artery disease that is designed to target anti-restenotic drugs specifically to diseased arterial sites and deliver doses not achievable with a drug ...

PLC Systems Inc.

PLC Medical Systems, Inc., the operating subsidiary of PLC Systems Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's lead product, RenalGuard®, significantly reduces the onset of CIN in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney...

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...

LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.

ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treat...

Vascular Solutions Incorporated

Vascular Solutions is a medical device company committed to providing superior clinical solutions for diagnostic and interventional vascular procedures. Founded in 1997, Vascular Solutions is a publicly held company that trades on the NASDAQ National Market under the symbol VASC. Our rapidly growing product line consists of innovative devices across established and emerging areas of coronary and...

Pivotal Research Centers

Pivotal Research Centers is one of the largest and most successful clinical research organizations in the nation. Having successfully completed over 450 research studies in over 20 indications, our sites are consistently top-enrolling in numerous studies and consistently delivers high-quality, clean data. Pivotal Research has extensive experience in multiple therapeutic areas with a focus in neuro...

Alucent Medical, Inc.

Alucent Medical, Inc. is a privately held biotechnology company headquartered in Salt Lake City, Utah. Alucent Medical was founded by Avera Health to develop and market Natural Vascular Scaffolding (NVS), a novel combination drug-device product for the treatment of patients suffering from peripheral vascular disease. Alucent Medical is currently conducting...

Atherton Venture Partners, LLC

Bacchus Vascular, Inc. is developing a safe, potentially less invasive, and more effective procedure to percutaneously remove blood clots from dialysis and peripheral grafts as well as native arteries and veins. In addition, the company is looking to develop additional products for de-bulking peripheral, coronary, and carotid vessels.

Vascular Architects, Inc.

Vascular Architects, Inc. designs, manufactures and markets instrumentation used in the treatment of vascular stenoses, occlusions and non-vascular obstructions. A key area of emphasis is the treatment of peripheral vascular disease, which manifests itself as a reduction or loss of blood flow due to the narrowing or closing of arteries.These products enable a less invasive treatment of patients co...

Bard Peripheral Vascular OEM Products

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

NuCryo Vascular LLC

NuCryo Vascular LLC is a privately held company that manufactures, markets, and sells the PolarCath (Cryoplasty) Balloon Dilatation System. NuCryo Vascular LLC is a subsidiary of Gemini Interventional Technologies, LLC. Gemini Interventional Technologies LLC is a privately held medical device start-up focused on developing, manufacturing, and marketing/sel...

t2cure GmbH

t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics to provide new treatment options to patients suffering from cardiac or peripheral vascular diseases like myocardial infarction or peripheral artery occlusive disease.

EKOS Corporation

EKOS Corporation pioneered the development and clinical application of ultrasonic accelerated drug delivery in medicine, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to ...

Tayside Flow Technologies Limited

TFT was formed in October 1998 as a spinout company from Tayside University Hospitals NHS TrustTayside Flow Technologies Ltd (TFT) is focused on the research, development and early stage commercialisation of vascular devices based on a new understanding of blood flow dynamics - Spiral Laminar Flow (SLF™ technology). The cardiovascular market is estimated at £11bn ($18bn equivalent) worldwide wi...

Vascular Pathways Inc.

Vascular Pathways, founded by Amir Belson, M.D., is a privately held medical device company focused on commercializing the Rapid IntraVascular Start (RIVS) catheter, an FDA cleared device enabling rapid, safe and successful peripheral IV insertion.

ev3

ev3 Inc. is a leading worldwide medical device company one hundred percent focused on catheter-based or endovascular technologies for the minimally invasive treatment of vascular disease and disorders. Our name signifies our commitment to serve the three endovascular markets – Peripheral Vascular, Cardiovascular and Neurovascular – and to be a global provider of products for underserved and em...


More From BioPortfolio on "Vascular Begins Enrollment Pivotal Study Drug Coated Peripheral"

Quick Search
Advertisement
 

Corporate Database Quicklinks